High CD79b Expression Predicts a Poor Outcome in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

被引：0
|
作者：
Del Poeta, Giovanni [1 ]
Del Principe, Maria Ilaria [1 ]
Zucchetto, Antonella [2 ]
Buccisano, Francesco [1 ]
Simotti, Cristina [1 ]
Maurillo, Luca [1 ]
Gianni, Laura [1 ]
Bulian, Pietro [2 ]
Venditti, Adriano [1 ]
Coletta, Angela [1 ]
Niscola, Pasquale [1 ]
de Fabritiis, Paolo [1 ]
Gattei, Valter [2 ]
Amadori, Sergio [1 ]
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
[2] Ctr Riferimento Oncol, Clin & Expt Hematol Res Unit, I-33081 Aviano, PN, Italy
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [31] A case report:: CD8 expression in B-cell chronic lymphocytic leukemia (B-CLL).: Prognostic significance of the aberrant CD8 expression
    Brunet, C
    Bardin, N
    Oukhouya, O
    Harlé, JR
    Zattara-Cannoni, H
    Dignat-George, F
    Sampol, J
    HEMATOLOGY AND CELL THERAPY, 1998, 40 (06) : 279 - 282
  • [32] The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis
    Cragg, MS
    Chan, HTC
    Fox, MD
    Tutt, A
    Smith, A
    Oscier, DG
    Hamblin, TJ
    Glennie, MJ
    BLOOD, 2002, 100 (09) : 3068 - 3076
  • [33] Utility of CD79b expression in the classification of B-cell chronic lymphoproliferative disorders (BCLPD).
    McCarron, KE
    Hsi, ED
    LABORATORY INVESTIGATION, 1999, 79 (01) : 142A - 142A
  • [34] Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia
    Thompson, AA
    Do, HN
    Saxon, A
    Wall, R
    LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) : 561 - 569
  • [35] A CASE OF CLASSICAL KAPOSIS-SARCOMA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    CONTU, L
    CARCASSI, C
    LANASA, G
    ZURRIDA, SM
    SIRIGU, F
    DELGIACCO, S
    CERIMELE, D
    LONGINOTTI, M
    PITZUS, F
    TUMORI, 1986, 72 (04) : 365 - 374
  • [36] CD5 negative (-) chronic B cell leukemias are rarely classifiable as B cell chronic lymphocytic leukemia (B-CLL)
    Huang, JC
    Finn, WG
    Variakojis, D
    Goolsby, CL
    Peterson, LC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 742 - 742
  • [37] GENETIC PREDISPOSITION OF AUTOIMMUNE-DISEASE AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    SHIRAI, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 173 (01): : 133 - 140
  • [38] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B
  • [39] Low expression of the B cell receptor in B-CLL is not related to genetic or transcriptional abnormalities of the B29 (CD79b) gene.
    Peyelle-Brogard, B
    Magnac, CC
    Dighiero, GG
    BLOOD, 2000, 96 (11) : 280B - 281B
  • [40] B-cell chronic lymphocytic leukemia (B-CLL) with 14Q32 translocations: Haematological features and clinical outcome
    Cavazzini, F.
    Hernandez, J. A.
    Gozzetti, A.
    Rossi, A. Russo
    Tiseo, R.
    Maffei, R.
    Bardi, A.
    Tammiso, E.
    Crupi, R.
    Lenoci, M. P.
    Marasca, R.
    Lauria, F.
    Torelli, G.
    Hernandez, J. M.
    Rigolin, G. M.
    Cuneo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 38 - 38
12345